Skip to main content
logo
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
28.39
-0.37 (-1.29%)
Oct 30, 2026, 4:00 PM EST - Market closed

Zenas BioPharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
110550-
Revenue Growth
-93.33%100.00%-90.00%--
Gross Profit
-212.47-158.06-134.14-10.03-61.69
Operating Income
-273.9-211.39-163.89-27.15-75.2
Net Income
-484.38-377.74-156.99-37.12-119.28
Earnings Per Share
-9.05-8.44-11.89-24.25-79.94
EPS Growth
-----

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
643.13343.19350.7756.8667.21
Total Debt
297.861.33121.111.53
Net Cash (Debt)
345.27341.87349.7635.7465.68
Net Cash Growth
26.81%-2.26%878.52%-45.58%-
Net Cash Per Share
6.457.6426.5023.3444.02

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-225.97-172.33-119.67-30.53-65.65
Capital Expenditures
-0-0.02-0.13-0.02-0.2
Free Cash Flow
-225.97-172.35-119.81-30.55-65.85
Free Cash Flow Growth
-----

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
----20.07%-
Operating Margin
-27390.10%-2113.85%-3277.76%-54.29%-
Pretax Margin
-48416.40%-3778.16%-3131.18%-73.65%-
Profit Margin
-48438.40%-3777.37%-3139.76%-74.25%-
FCF Margin
-22597.40%-1723.51%-2396.10%-61.09%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
1850.37194.9168.45--